Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

Kurdoglu, Mertihan; YILDIRIM, MÜLAZİM; Kurdoglu, Zehra; ERDEM, AHMET; ERDEM, MEHMET; BİLGİHAN, AYŞE; Goktas, Bulent

doi:10.3109/09513590.2010.501879

Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

Atıf İçin Kopyala

Kurdoglu M., YILDIRIM M., Kurdoglu Z., ERDEM A., ERDEM M., BİLGİHAN A., ...Daha Fazla

GYNECOLOGICAL ENDOCRINOLOGY, cilt.27, ss.551-557, 2011 (SCI İndekslerine Giren Dergi)

Cilt numarası: 27 Konu: 8
Basım Tarihi: 2011
Doi Numarası: 10.3109/09513590.2010.501879
Dergi Adı: GYNECOLOGICAL ENDOCRINOLOGY
Sayfa Sayıları: ss.551-557

Özet

Objective. To investigate the effect of intranasal estrogen replacement therapy administered to postmenopausal women alone or in combination with progesterone on markers of cardiovascular risk.